Home/Filings/4/0001209191-21-032971
4//SEC Filing

Mahadevan Chids 4

Accession 0001209191-21-032971

CIK 0001697532other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 8:08 PM ET

Size

8.2 KB

Accession

0001209191-21-032971

Insider Transaction Report

Form 4
Period: 2021-05-10
Mahadevan Chids
Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2021-05-10+8,5448,544 total
  • Award

    Stock Option (Right to Buy)

    2021-05-10+13,41213,412 total
    Exercise: $17.05Exp: 2031-05-10Common Stock (13,412 underlying)
Holdings
  • Common Stock

    25
Footnotes (2)
  • [F1]Consists of Restricted Stock Units, representing a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the Restricted Stock Units were vested upon grant and one-fourth (1/4th) of the Restricted Stock Unites shall vest thereafter on each of May 10, 2022, May 10, 2023 and May 10, 2024,subject to the Reporting Person continuing to provide services through each such date.
  • [F2]One-fourth (1/4th) of the shares subject to the Option were vested upon grant and the remainder of the shares subject to the Option shall vest thereafter in equal monthly installments over the three-year period following the date of grant, subject to the Reporting Person continuing to provide services through each such date.

Issuer

Applied Therapeutics Inc.

CIK 0001697532

Entity typeother

Related Parties

1
  • filerCIK 0001808486

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 8:08 PM ET
Size
8.2 KB